173 related articles for article (PubMed ID: 23553342)
1. The evolving role of antifungal susceptibility testing.
Eschenauer GA; Carver PL
Pharmacotherapy; 2013 May; 33(5):465-75. PubMed ID: 23553342
[TBL] [Abstract][Full Text] [Related]
2. Antifungal susceptibility testing: a primer for clinicians.
Kuper KM; Coyle EA; Wanger A
Pharmacotherapy; 2012 Dec; 32(12):1112-22. PubMed ID: 23165897
[TBL] [Abstract][Full Text] [Related]
3. Role of antifungal susceptibility testing in patient management.
Forrest G
Curr Opin Infect Dis; 2006 Dec; 19(6):538-43. PubMed ID: 17075328
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of in vitro antifungal susceptibility testing.
Espinel-Ingroff A
Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance.
Espinel-Ingroff A; Warnock DW; Vazquez JA; Arthington-Skaggs BA
Med Mycol; 2000; 38 Suppl 1():293-304. PubMed ID: 11204157
[TBL] [Abstract][Full Text] [Related]
6. [Mycoses].
Yamazumi T; Furuta I
Rinsho Byori; 2002 Sep; 50(9):853-9. PubMed ID: 12386962
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.
Kanafani ZA; Perfect JR
Clin Infect Dis; 2008 Jan; 46(1):120-8. PubMed ID: 18171227
[TBL] [Abstract][Full Text] [Related]
8. Breakpoints for posaconazole susceptibility testing: background and discussion about the need of establishing values.
Fleck R; Hof H
Mycoses; 2008 Sep; 51 Suppl 2():1-4. PubMed ID: 18721327
[TBL] [Abstract][Full Text] [Related]
9. EUCAST breakpoints for antifungals.
Rodríguez-Tudela JL; Arendrup MC; Cuenca-Estrella M; Donnelly JP; Lass-Flörl C
Drug News Perspect; 2010 Mar; 23(2):93-7. PubMed ID: 20369073
[TBL] [Abstract][Full Text] [Related]
10. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.
Cuenca-Estrella M; Rodriguez-Tudela JL
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):267-76. PubMed ID: 20192681
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility testing in fungi: a global perspective on a variety of methods.
Lass-Flörl C; Perkhofer S; Mayr A
Mycoses; 2010 Jan; 53(1):1-11. PubMed ID: 20078786
[TBL] [Abstract][Full Text] [Related]
12. Standardization of antifungal susceptibility testing and clinical relevance.
Espinel-Ingroff A; Barchiesi F; Hazen KC; Martinez-Suarez JV; Scalise G
Med Mycol; 1998; 36 Suppl 1():68-78. PubMed ID: 9988494
[TBL] [Abstract][Full Text] [Related]
13. Issues in antifungal susceptibility testing.
Johnson EM
J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i13-8. PubMed ID: 18063599
[TBL] [Abstract][Full Text] [Related]
14. Invasive candidiasis and the utility of antifungal susceptibility testing in the ICU.
Coyle EA
J Pharm Pract; 2010 Feb; 23(1):33-7. PubMed ID: 21507791
[TBL] [Abstract][Full Text] [Related]
15. [An update on antifungal susceptibility testing].
Tapia P CV
Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
[TBL] [Abstract][Full Text] [Related]
16. Antifungal Susceptibility Testing: Current Approaches.
Berkow EL; Lockhart SR; Ostrosky-Zeichner L
Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32349998
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibility testing. New technology and clinical applications.
Pfaller MA; Yu WL
Infect Dis Clin North Am; 2001 Dec; 15(4):1227-61. PubMed ID: 11780273
[TBL] [Abstract][Full Text] [Related]
18. Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.
Pfaller MA; Castanheira M; Diekema DJ; Messer SA; Jones RN
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):252-9. PubMed ID: 21917395
[TBL] [Abstract][Full Text] [Related]
19. [Results of antifungal susceptibility testing of Candida species and trends of antifungal use in Niigata university medical and dental hospital].
Aoki T; Moro H; Koshio N; Tamura T; Tanabe Y; Kawai H; Matsuto T; Okada M
Rinsho Byori; 2010 Jul; 58(7):658-63. PubMed ID: 20715508
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of antifungal susceptibility: Review of literature.
Hadrich I; Ayadi A
J Mycol Med; 2018 Sep; 28(3):574-584. PubMed ID: 29773435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
